Pulmonary Pharmacology Flashcards

(88 cards)

1
Q

Inhaled bronchodilator for symptom relief and acute bronchodilation

A

Short-acting B agonists (SABAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Can be used in asthma, COPD and exercise-induced bronchospasm

A

Albuterol (salbutamol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inhaled dose of albuterol )salbutamol

A

180 ug (2 puffs) every 4 to 6 hrs as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Nebulized dose of albuterol (salbutamol)

A

2.5 mg via oral inhalation every 6-8 hrs as needed over 5-15 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Oral dose of albuterol (salbutamol)

A

2-4 mg by mouth every 6-8 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Albuterol(salbutamol) can be inhaled as

A

Levalbuterol (active isomer so half the dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SABA bronchodilator that is inhaled through MDI nebulizer

A

Levalbuterol

L-albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SABA which is similar to albuterol given via MDI nebulizer

A

Pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dose of pirbuterol

A

400 ug (2 puffs) every 4-6 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of SABAs

A

Albuterol (salbutamol)
Levalbuterol (L-albuterol)
Pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Add on therapy to ICS in asthma and can be used alone in COPD

A

Long-acting B agonists (LABAs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of LABAs

A
Formoterol
Arformoterol
Salmeterol
Indacaterol
Olodaterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LABAs for Asthma add-on to ICS

A

Formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LABA used for maintenance and treatment of severe COPD

A

Formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inhaled dose of formoterol

A

12 ug every 12 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nebulized dose of formoterol

A

20 ug in 2 ml twice per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LABA used as reliever of bronchospasm

A

Formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

LABA used for severe COPD

A

Arformoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

LABA used in maintenance for treatment for COPD

A

Salmeterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Inhaled dose of arformoterol

A

15 ug in 2 ml twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Inhaled dose of salmeterol

A

50 ug twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Inhaled dose of indacaterol

A

Inhaled (DPI) 75 cetazolamide once daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Inhaled dose olodaterol

A

2.5 cetazolamide once daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Muscarinic receptor antagonists inhaled as bronchodilators

A

Anticholinergics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Examples of anticholinergics
``` Ipratropium bromide Albuterol/ipatropium combination Tiotropium bromide Umeclidinium bromide Aclidium bromide Glycopyrrolate ```
26
Inhaled dose of ipratropium bromide
2 puffs (17 ug/puff) 3-4x a day
27
Dose of albuterol/ipratropium combination
Albuterol 103 ug/ipratropium 18 ug/puff | 2 puffs 4 times daily
28
Ipratropium bromide are replaced by
LAMAs
29
Anticholinergics that should be avoided spraying in the eyes
Ipratropium bromide
30
Adverse effects of ipratropium
Dry mouth, Tachycardia, urinary retention, glaucoma
31
Dose of tiotropium bromide
2.5 ug via oral inhalation (2 puffs of 1.25 ug/actuation) once daily
32
Anticholinergics that should be a caution in patients with urinary retention or glaucoma history
Tiotropium bromide
33
Inhaled dose (DPI) of umeclidinium bromide
6.25 ug (1 puff) once daily
34
Inhaled dose (DPI) of aclidinium bromide
400 ug (1 puff) once daily
35
Inhaled dose (DPI) of glycopyrrolate
1 capsule (15.6 ug) inhaled twice daily
36
Combination inhalers for the maintenance treatment of COPD
LAMA-LABA combination inhalers
37
Examples of LAMA-LABA combination inhalers
Glycopyrrolate/ Umeclinium/Vilanterol Tiotropium/olodaterol
38
Maintenance treatment for asthma
Inhaled corticosteroids
39
Examples of corticosteroids
1. Beclomethasone (dipropionate) BDP 2. Fluticasone propionate 3. Budesonide 4. Ciclesonide
40
Inhaled dose of beclomethasone
MDI/PDI 88 ug (1 spray= 44 ug) twice daily
41
Has more systemic than any other ICS
Beclomethasone dipropionate
42
Local effects of Beclomethasone
Hoarse voice | Candidiasis
43
Systemic effects of Beclomethasone
Growth suppression Bruising Adrenal suppression
44
Beclomethasone dipropionate should not exceed
440 ug twice daily
45
Inhaled dose of fluticasone propionate
MDI/DPI | 50, 100, 250 ug 2 puffs, twice daily
46
Dose of fluticaosne should exceed
1000 ug daily
47
ICS that has fewer systemic effects than BDP
Fluticasone propionate
48
Inhaled dose of budesonide
Inhaled via jet nebulizer either once daily or divided into 2 doses (maximum daily dose 0.5 mg/d
49
ICS that is used in children less than 8 who cannot use PDI
Budesonide
50
Inhaled dose of ciclesonide
MDI 80 ug twice daily
51
Has the least-systemic effects of all ICS and maybe effective once daily
Ciclesonide
52
Maintenance treatment in asthma and COPD
ICS/LABA Combination inhalers
53
Examples of ICS/LABA combination
Fluticasone propionate/salmeterol Budesonide/formoterol Fluticasone furoate/vilanterol
54
ICS/LABA combination where the starting dose should be based on the asthma severity
Fluticasone propionate/salmeterol
55
Inhaled dose of budesonide/formoterol
Inhaled MDI 80 ug budesonide and 4.5 ug formoterol per inhalation twice daily
56
Inhaled dose of fluticasone furoate/vilanterol
Inhaled DPI 1 inhalation | Fluticasone furoate 100 ug/vilanterol 25 ug once daily
57
ICS/LABA combi that Uses lowest-dose that maintains asthma control
Fluticasone propionate/salmeterol
58
ICS/LABA combination that is used only in severe COPD or asthma-COPD overlap
Fluticasone propionate/salmeterol
59
Short course or oral maintenance for asthma and COPD
Systemic corticosteroids
60
Examples of systemic corticosteroids
Prednisone Prednisolone Hydrocortisone succinate Methyprednisolone
61
Oral dose of prednisone
40-80 mg once daily or divided dose for 3-10 days for acute exacerbation
62
Systemic corticosteroids that has minimal dose for maintenance
Prednisone
63
Dose of hydrocortisone succinate
IM/IV: 100-500 mg every 12 h for acute severe asthma
64
Systemic corticosteroids for patients not able to take oral steroids
Hydrocortisone succinate
65
Dose of methylprednisolone
IV: 100-1000 mg for acute severe asthma
66
Systemic corticosteroids that is rarely indicated because of steroids side effects
Methyprednisolone
67
Antileukotrienes for Asthma Maintenance
Montelukast Zafirlukast Zileuton
68
Oral dose of montelukast
10 mg/day
69
Oral dose of Zafirlukast
20 mg twice per day
70
Oral dose of Zileuton
600 mg four times/d or 1200 mg twice/d
71
Antileukotrienes that causes hepatic dysfunction
Zileuton
72
Adverse effects of antileukotrienes
Headache | Churg-Strauss syndrome
73
Add-on maintenance for SEVERE asthma and COPD
Methylxanthines
74
Examples of methylxanthines
Theophylline (oral) | Aminophylline (IV)
75
Methylxanthines used for severe exacerbation that does not respond to nebulized B agonists
Aminophylline (IV)
76
Maintenance for severe COPD
Phosphodiesterase 4 Inhibitor
77
Example of PDE4 Inhibitor
Roflumilast
78
Oral dose of roflumilast
500 ug once daily
79
Maintenance treatment for severe asthma
Omalizumab
80
Administration of Omalizumab
Subcutaneous administration
81
Dose of Omalizumab
Dose depends on total IgE: given every 2-4 weeks
82
Adverse effects of Omalizumab
Occasional headache and anaphylaxis
83
PDE4 inhibitor added to maximal inhaled therapy if severe disease with acute exacerbations and chronic bronchitis
Roflumilast
84
ICS with reduced oral bioavailability thus reduced adverse effects (BFMC)
Budesonide Fluticasone Mometasone Ciclesonide
85
Preferred ICS in patients who need high doses of ICSs in children
>1000 ug Budesonide Fluticasone propionate
86
ICS with longest duration of action and suitable for once-daily dosing
Fluticasone furoate
87
Reverses reduction in HDAC2 expression that reduces corticosteroids responsiveness in severe asthma
Low-dose theophylline | Nortriptyline
88
PDE subfamily important for anti-inflammatory effects
PDE4B